HER-2 Positive Breast Cancer Recruiting Phase 3 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0042425 (HER-2 Positive Breast Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02947685Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast CancerTreatment